Literature DB >> 17461698

Development and reliability testing of the clinical pharmacist recommendation taxonomy.

Angela B Hoth1, Barry L Carter, Jose Ness, Anjan Bhattacharyya, Ronald I Shorr, Gary E Rosenthal, Peter J Kaboli.   

Abstract

STUDY
OBJECTIVE: To evaluate the reliability of a newly developed taxonomy--the Clinical Pharmacist Recommendation (CPR) taxonomy--to classify clinical pharmacy interventions.
DESIGN: The CPR taxonomy was developed and refined in three phases. In each phase, reviewers independently reviewed recommendations made by a clinical pharmacist-physician team and categorized them into mutually exclusive categories: priority, problem, and response. Interrater reliability was assessed for all categories during each development phase.
SETTING: Primary care clinics of a Veterans Affairs Medical Center. PATIENTS: Fifty-three patients enrolled in the Veterans Affairs Enhanced Pharmacy Outpatient Clinic (EPOC) trial.
MEASUREMENTS AND MAIN RESULTS: Interrater reliability was assessed using the kappa statistic. A total of 423 recommendations were evaluated during the three testing phases. In the final testing phase, agreement was moderate for pharmacotherapy problem subcategories (kappa = 0.57), substantial for pharmacotherapy problem primary categories (kappa = 0.64), and almost perfect for response categories (kappa = 0.85). Taxonomy completion time/patient averaged 4.6 minutes (range 1-11 min).
CONCLUSION: The CPR taxonomy provides a reliable method to systematically evaluate clinical pharmacy recommendations based on the therapeutic problem identified and specific action recommended to resolve the problem.

Entities:  

Mesh:

Year:  2007        PMID: 17461698     DOI: 10.1592/phco.27.5.639

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  10 in total

1.  Pharmacist review and its impact on Singapore nursing homes.

Authors:  Hui Shan Chia; John Aik Hui Ho; Bernadette Daolin Lim
Journal:  Singapore Med J       Date:  2015-09       Impact factor: 1.858

2.  The Iowa Continuity of Care study: Background and methods.

Authors:  Barry L Carter; Karen B Farris; Paul W Abramowitz; David B Weetman; Peter J Kaboli; Jeffrey D Dawson; Paul A James; Alan J Christensen; John M Brooks
Journal:  Am J Health Syst Pharm       Date:  2008-09-01       Impact factor: 2.637

3.  Cluster-Randomized Trial to Evaluate a Centralized Clinical Pharmacy Service in Private Family Medicine Offices.

Authors:  Barry L Carter; Barcey Levy; Brian Gryzlak; Yinghui Xu; Elizabeth Chrischilles; Jeffrey Dawson; Mark Vander Weg; Alan Christensen; Paul James; Linnea Polgreen
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2018-06

4.  A national drug related problems database: evaluation of use in practice, reliability and reproducibility.

Authors:  Lene Juel Kjeldsen; Trine Birkholm; Hanne Fischer; Trine Graabæk; Merete Kjær Hansen; Karina Porsborg Kibsdal; Lene Vestergaard Ravn-Nielsen; Tania Holtum Truelshøj
Journal:  Int J Clin Pharm       Date:  2014-06-05

5.  Development and testing of a tool for assessing and resolving medication-related problems in older adults in an ambulatory care setting: the individualized medication assessment and planning (iMAP) tool.

Authors:  Ginny D Crisp; Jena Ivey Burkhart; Denise A Esserman; Morris Weinberger; Mary T Roth
Journal:  Am J Geriatr Pharmacother       Date:  2011-11-04

6.  Agreement between drugs-to-avoid criteria and expert assessments of problematic prescribing.

Authors:  Michael A Steinman; Gary E Rosenthal; C Seth Landefeld; Daniel Bertenthal; Peter J Kaboli
Journal:  Arch Intern Med       Date:  2009-07-27

7.  Acceptance of recommendations by inpatient pharmacy case managers: unintended consequences of hospitalist and specialist care.

Authors:  Sammuel V Anderegg; David E Demik; Barry L Carter; Jeffrey D Dawson; Karen Farris; Constance Shelsky; Peter Kaboli
Journal:  Pharmacotherapy       Date:  2013-01       Impact factor: 4.705

8.  A centralized cardiovascular risk service to improve guideline adherence in private primary care offices.

Authors:  Barry L Carter; Barcey T Levy; Brian Gryzlak; Elizabeth A Chrischilles; Mark W Vander Weg; Alan J Christensen; Paul A James; Carol A Moss; Christopher P Parker; Tyler Gums; Rachel J Finkelstein; Yinghui Xu; Jeffrey D Dawson; Linnea A Polgreen
Journal:  Contemp Clin Trials       Date:  2015-05-04       Impact factor: 2.226

9.  Influence of pharmacist intervention on drug safety of geriatric inpatients: a prospective, controlled trial.

Authors:  Angela Nachtigall; Hans J Heppner; Petra A Thürmann
Journal:  Ther Adv Drug Saf       Date:  2019-04-16

Review 10.  Investigating the Relative Significance of Drug-Related Problem Categories.

Authors:  Lene Juel Kjeldsen; Trine Rune Høgh Nielsen; Charlotte Olesen
Journal:  Pharmacy (Basel)       Date:  2017-06-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.